Skip to main content

Together we are beating cancer

Donate now

Health & Medicine

Find out more about the latest cancer treatments, clinical trials, cancer prevention and health policy
Showing 12 out of 3490 results
  • Science & Technology
  • Health & Medicine
  • For Researchers

Why diversity in STEM is vital to cancer research

Cancer Research UK has an important role in fostering a diverse and inclusive research environment, and here we give a brief summary of our response to the consultation and explain why this matters for cancer research… Cancer Research UK has an important role in fostering a diverse and inclusive research environment, and here we give a brief summary of our response to the consultation and explain why this matters for cancer research…

by Cancer Research UK | Analysis | 3 March 2022

3 March 2022

This entry is part 4 of 10 in the series Diversity in research
%postcontent%
A consultation with 2 people and a doctor

The first analysis in over 10 years looking at which ethnic groups in England are more likely to get cancer has now been published by Cancer Research UK analysts.  The first analysis in over 10 years looking at which ethnic groups in England are more likely to get cancer has now been published by Cancer Research UK analysts. 

by Cancer Research UK | Analysis | 2 March 2022

2 March 2022

Breast cancer exam.

Research finds women with breast pain alone were no more to receive a diagnosis of breast cancer than women with no symptoms. Research finds women with breast pain alone were no more to receive a diagnosis of breast cancer than women with no symptoms.

by Lilly Matson | News | 22 February 2022

22 February 2022

Illustration showing inequalities.

We talk to Professor Sir Michael Marmot, who's been at the forefront of health inequality research for decades, to discuss what it is and how we can reduce it. We talk to Professor Sir Michael Marmot, who's been at the forefront of health inequality research for decades, to discuss what it is and how we can reduce it.

by Harry Jenkins | Analysis | 15 February 2022

15 February 2022

This entry is part 1 of 5 in the series Health inequalities
%postcontent%
Breast cancer tissue under the microscope.

A study by Oxford University has found that aromatase inhibitors are better than tamoxifen at reducing the risk of breast cancer recurrence in both younger and older women. A study by Oxford University has found that aromatase inhibitors are better than tamoxifen at reducing the risk of breast cancer recurrence in both younger and older women.

by In collaboration with PA Media Group | News | 11 February 2022

11 February 2022

A photograph of a lab at the Imperial Cancer Research Fund in the 1960's.
  • Science & Technology
  • Health & Medicine

Diving into our role in 50 top cancer drugs

To mark 20 years since the merger of the Cancer Research Campaign and the Imperial Cancer Research Fund, we’ve delved into the research of the charities' that led to many of the drugs in use today. To mark 20 years since the merger of the Cancer Research Campaign and the Imperial Cancer Research Fund, we’ve delved into the research of the charities' that led to many of the drugs in use today.

by Catherine Pickworth | In depth | 9 February 2022

9 February 2022

Michelle Mitchell chief executive Cancer Research UK
  • Health & Medicine
  • Policy & Insight

Javid's war on cancer can't leave people behind

We’ve had plans before. What we need is leadership, commitment and competence. Addressing cancer inequalities and cancer prevention must be central to the plan. We’ve had plans before. What we need is leadership, commitment and competence. Addressing cancer inequalities and cancer prevention must be central to the plan.

by Michelle Mitchell | Opinion | 4 February 2022

4 February 2022

The UK Government has set out how they'll help parts of the country to catch up on a range of measures, including health. The UK Government has set out how they'll help parts of the country to catch up on a range of measures, including health.

by Matt Sample | Analysis | 2 February 2022

2 February 2022

Computational analysis of cancer

From a legacy of life-saving medicines to developing new tools to detect cancer, our scientists have been at the forefront of cancer research for 120 years. From a legacy of life-saving medicines to developing new tools to detect cancer, our scientists have been at the forefront of cancer research for 120 years.

by Katie Roberts | Analysis | 2 February 2022

2 February 2022